Quantcast

Latest Stem cell treatments Stories

2014-05-12 08:33:28

ROCKVILLE, Md., May 12, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported its financial results for the three months ended March 31, 2014 and provided a business and clinical update. "During the first quarter of 2014, we continued to advance the NSI-566 cell therapy platform through human clinical trials. We have completed treatment of the fourth cohort in our ALS Phase II escalating dose trials, in collaboration with our sites at University of Michigan, Emory and...

2014-05-12 08:33:04

SAN DIEGO, May 12, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) today announced that the Company's Excellagen(®) flowable dermal matrix in combination with Orbsen Therapeutics' mesenchymal stromal stem cell therapy Cyndacel-M(TM) has been selected for clinical evaluation in a Phase 1b safety study for the potential treatment of chronic diabetic wounds to be funded by the European Union under EU Framework 7 (FP7). The project, known by the...

2014-05-12 08:32:37

DUBLIN, May 12, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/sqctb8/stem_cell_therapy) has announced the addition of the "Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The...

2014-05-09 23:09:06

Tom McManus, former professional football player with Jacksonville Jaguars, is teaming up with SmartChoice® Stem Cell Institute as a spokesperson to promote awareness of benefits and success of Adult Stem Cell procedures as non-surgical treatment for sports injuries, arthritis, joint and back pain. Jacksonville, FL (PRWEB) May 09, 2014 Tom McManus, former professional football player with the Jacksonville Jaguars is teaming up with SmartChoice® Stem Cell Institute as a...

2014-05-08 23:12:39

Dr. Jeffrey Adler and Dr. Darline Kulhan both of Adler Footcare New York will be featured on NewsTalkRadio 77 WABC on May 10 to discuss stem cell replacement therapy and HyProCure, new treatment options available for painful foot problems. New York, NY (PRWEB) May 08, 2014 New York podiatrists Dr. Jeffrey Adler and Dr. Darline Kulhan, will be interviewed by radio personality Laura Smith on New York talk show 77 WABC about the use of stem cells and a procedure called HyProCure, both used...

2014-05-08 12:29:52

SALT LAKE CITY, May 8, 2014 /PRNewswire-USNewswire/ -- Mice severely disabled by a multiple sclerosis (MS) - like condition could walk less than two weeks following treatment with human stem cells. The finding, which uncovers new avenues for treating MS, will be published online on May 15, 2014, in the journal Stem Cell Reports. http://photos.prnewswire.com/prnvar/20140205/DC59634LOGO When scientists transplanted human stem cells into MS mice, they predicted the cells would be...

2014-05-08 08:34:19

ROCKVILLE, Md., May 8, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced the appointment of Sandford Drexel Smith to its Board of Directors, bringing the total number of board members to seven, five of whom are independent. Mr. Smith is the former President, International Group, and Executive Vice President of Genzyme Corporation. He also served on Genzyme's Executive Committee, where he reported directly to the Chairman and CEO. As President of the International Group,...

2014-05-06 16:31:58

NEW YORK, May 6, 2014 /PRNewswire/ -- Brian Mehling, M.D., an American orthopedic trauma surgeon and founder of Blue Horizon International, was awarded a temporary license to practice medicine in Nigeria. Dr. Mehling, a researcher and philanthropist, is spearheading groundbreaking research in stem cell therapy focused on the health benefits of cell therapy in treating and managing diseases.Blue Horizon International is a healthcare consulting company with a unique concept that...

2014-05-05 23:01:46

Irvine Stem Cell Treatment Center takes their lecture on the road to Fountain Valley, Yorba Linda, and Laguna Woods. Irvine, California (PRWEB) May 05, 2014 The Irvine Stem Cell Treatment Center, PC, located in Irvine, California, announces a series of free public seminars on the use of stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief. The tour dates and locations are as follows: Wednesday, May 7, 2014 @...

2014-05-05 23:00:23

Tennis elbow is a common condition affecting 40-60 years aged adults. Though it is not a critical condition, it is potentially disabling in the sense that it restricts the certain activities of tennis players. Los Angeles, CA (PRWEB) May 05, 2014 Tennis elbow is a common condition affecting 40-60 years aged adults. Though it is not a critical condition, it is potentially disabling in the sense that it restricts the certain activities of tennis players. MetroMD Institute of Regenerative...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related